Chestnut Hill, MA1 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Chestnut Hill, MA

Find 1 actively recruiting myalgic encephalomyelitis clinical trials in Chestnut Hill, MA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
40
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Chestnut Hill

About Myalgic Encephalomyelitis Clinical Trials in Chestnut Hill

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 1 myalgic encephalomyelitis clinical trials recruiting participants in Chestnut Hill, MA. These studies are seeking a combined 40 participants. Research is being sponsored by Boston College. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Chestnut Hill — FAQ

Are there myalgic encephalomyelitis clinical trials in Chestnut Hill?

Yes, there are 1 myalgic encephalomyelitis clinical trials currently recruiting in Chestnut Hill, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chestnut Hill?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chestnut Hill research site will contact you about next steps.

Are clinical trials in Chestnut Hill free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chestnut Hill studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 1 active trials in Chestnut Hill are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 21, 2026 from ClinicalTrials.gov